| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5624668 | AM REGENT | Iron dextran formulations |
Sep, 2015
(8 years ago) | |
Dexferrum is owned by Am Regent.
Dexferrum contains Ferric Oxyhydroxide.
Dexferrum has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Dexferrum are:
- US5624668
Dexferrum was authorised for market use on 23 February, 1996.
Dexferrum is available in injectable;injection dosage forms.
The generics of Dexferrum are possible to be released after 29 September, 2015.
Drugs and Companies using FERRIC OXYHYDROXIDE ingredient
Market Authorisation Date: 23 February, 1996
Treatment: NA
Dosage: INJECTABLE;INJECTION
More Information on Dosage
DEXFERRUM family patents
